| Product NDC: | 0004-0298 | 
| Proprietary Name: | CellCept | 
| Non Proprietary Name: | Mycophenolate Mofetil hydrochloride | 
| Active Ingredient(s): | 500 mg/20mL & nbsp; Mycophenolate Mofetil hydrochloride | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0004-0298 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA050758 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19981001 | 
| Package NDC: | 0004-0298-09 | 
| Package Description: | 4 VIAL in 1 CARTON (0004-0298-09) > 20 mL in 1 VIAL | 
| NDC Code | 0004-0298-09 | 
| Proprietary Name | CellCept | 
| Package Description | 4 VIAL in 1 CARTON (0004-0298-09) > 20 mL in 1 VIAL | 
| Product NDC | 0004-0298 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Mycophenolate Mofetil hydrochloride | 
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 19981001 | 
| Marketing Category Name | NDA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 
| Strength Number | 500 | 
| Strength Unit | mg/20mL | 
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |